Estrogen receptor isoform-specific regulation of endogenous gene expression in human osteoblastic cell lines expressing either ER? or ER?

2003 ◽  
Vol 90 (2) ◽  
pp. 315-326 ◽  
Author(s):  
David G. Monroe ◽  
Barbara J. Getz ◽  
Steven A. Johnsen ◽  
B. Lawrence Riggs ◽  
Sundeep Khosla ◽  
...  
2016 ◽  
Vol 35 (2) ◽  
pp. 150-160 ◽  
Author(s):  
Flor M. Pérez-Campo ◽  
Tobias May ◽  
Jeannette Zauers ◽  
Carolina Sañudo ◽  
Jesús Delgado-Calle ◽  
...  

Bone ◽  
2000 ◽  
Vol 26 (4) ◽  
pp. 325-331 ◽  
Author(s):  
S.A. Harris ◽  
M. Zhang ◽  
L.S. Kidder ◽  
G.L. Evans ◽  
T.C. Spelsberg ◽  
...  

Sarcoma ◽  
2012 ◽  
Vol 2012 ◽  
pp. 1-13 ◽  
Author(s):  
Roman Muff ◽  
Ram Mohan Ram Kumar ◽  
Sander M. Botter ◽  
Walter Born ◽  
Bruno Fuchs

Osteosarcoma (OS) is a rare bone neoplasm that affects mainly adolescents. It is associated with poor prognosis in case of metastases formation. The search for metastasis predicting markers is therefore imperative to optimize treatment strategies for patients at risk and important for the search of new drugs for the treatment of this devastating disease. Here, we have analyzed by microarray the differential gene expression in four human and two mouse OS cell line systems consisting of parental cell lines with low metastatic potential and derivatives thereof with increased metastatic potential. Using two osteoblastic cell line systems, the most common OS phenotype, we have identified forty-eight common genes that are differentially expressed in metastatic cell lines compared to parental cells. The identified subset of metastasis relevant genes in osteoblastic OS overlapped only minimally with differentially expressed genes in the other four preosteoblast or nonosteoblastic cell line systems. The results imply an OS phenotype specific expression pattern of metastasis regulating proteins and form a basis for further investigation of gene expression profiles in patients’ samples combined with survival analysis with the aim to optimize treatment strategies to develop new drugs and to consequently improve the survival of patients with the most common form of osteoblastic OS.


2012 ◽  
Vol 48 ◽  
pp. 58
Author(s):  
S. Grooby ◽  
H.M. Astley ◽  
J. Elliott ◽  
T. Henley ◽  
K.M. Pytel ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document